Measles-containing-vaccine second-dose (MCV2) immunization coverage in Upper-middle income (World Bank)
Upper-middle income (World Bank): Measles-containing-vaccine second-dose (MCV2) immunization coverage was 83.0% in 2025. ▲ Rising
Latest (2025)
83.0%
Change on year
down 2.4%
Rank
5th
of 11 groups
All-time high
88.0%
in 2018
All-time low
26.0%
in 2000
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Upper-middle income (World Bank), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Upper-middle income (World Bank) is 83.0%, measured in 2025.
Compared with earlier readings it is down 2.4% on the previous year and unchanged over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Upper-middle income (World Bank) peaked at 88.0% in 2018 and was at its lowest, 26.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 26.0% | — |
| 2001 | 30.0% | +15.4% |
| 2002 | 30.0% | +0.0% |
| 2003 | 32.0% | +6.7% |
| 2004 | 33.0% | +3.1% |
| 2005 | 65.0% | +97.0% |
| 2006 | 72.0% | +10.8% |
| 2007 | 74.0% | +2.8% |
| 2008 | 78.0% | +5.4% |
| 2009 | 82.0% | +5.1% |
| 2010 | 82.0% | +0.0% |
| 2011 | 85.0% | +3.7% |
| 2012 | 85.0% | +0.0% |
| 2013 | 84.0% | -1.2% |
| 2014 | 82.0% | -2.4% |
| 2015 | 83.0% | +1.2% |
| 2016 | 86.0% | +3.6% |
| 2017 | 86.0% | +0.0% |
| 2018 | 88.0% | +2.3% |
| 2019 | 85.0% | -3.4% |
| 2020 | 83.0% | -2.4% |
| 2021 | 82.0% | -1.2% |
| 2022 | 85.0% | +3.7% |
| 2023 | 83.0% | -2.4% |
| 2024 | 85.0% | +2.4% |
| 2025 | 83.0% | -2.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 52.2% | 26.0% | 82.0% | 10 |
| 2010s | 84.6% | 82.0% | 88.0% | 10 |
| 2020s | 83.5% | 82.0% | 85.0% | 6 |
More health data for Upper-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 10.32 % change on previous year (2025)
- Diphtheria - number of reported cases 1,556 (2025)
- Total tetanus - number of reported cases 5,773 (2025)
- Pertussis - number of reported cases 63,803 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Upper-middle income (World Bank)?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Upper-middle income (World Bank) was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Upper-middle income (World Bank)?
- The highest recorded value was 88.0% in 2018.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 26.0% in 2000.
- How does Upper-middle income (World Bank) rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Upper-middle income (World Bank) ranks 5th out of 11 groups with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).